Transplantable dopamine neurons produced from stem cells could expedite treatment options for Parkinson's disease.
Researchers identify a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson’s disease. The study implicates two genetic variants that disrupt protein sorting in neurons.
Researchers transplanted neural cells, derived from adult skin cells, into monkeys; where they developed into several different types of brain cells. The research could eventually help provide new treatment avenues for patients with a wide range of neurological diseases.
Dopamine neurons are activated less than in adults brains when teens are faced with the prospect of a reward, a new study reports.